Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

Sponsor

Rebiscan, Inc. (Industry)

Overall Status

Completed

CT.gov ID

NCT01706991

Collaborator

University of Southern California (Other)

Enrollment

Location

Duration (Months)

6.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus. All tests and observations will be done at a single visit over the course of approximately 30 minutes.

Condition or Disease	Intervention/Treatment	Phase
Amblyopia Strabismus	Device: Pediatric Vision Scanner eye scan

Study Design

Study Type:

Observational

Actual Enrollment :

32 participants

Observational Model:

Case-Control

Time Perspective:

Prospective

Official Title:

MEPEDS New Device Pediatric Vision Scanner

Study Start Date :

Jan 1, 2011

Actual Primary Completion Date :

Jun 1, 2011

Actual Study Completion Date :

Jun 1, 2011

Arms and Interventions

Arm	Intervention/Treatment
Normal Controls Structurally normal eye with equal visual acuity and normal stereopsis.	Device: Pediatric Vision Scanner eye scan Subject is scanned with a 2.5 second pediatric vision scanner device test.
Referral required Diagnosed with amblyopia or constant strabismus, categorized based on the GSE. Amblyopia: VA <20/40 and 2 logMAR lines difference in normal eye Mild amblyopia (>20/40) Moderate amblyopia (20/40 and <20/100) Severe amblyopia (≥20/100 or worse) Bilateral amblyopia: >4 years age VA<20/40 OU including high hyperopia or high astigmatism. Strabismus: Constant: >2 PD at near and or distance. Intermittent: strabismus that could be controlled intermittently either through fusional mechanisms or a compensatory head position. Amblyogenic factor categorization: 'Anisometropia'- (1.5 Diopters (D) or more difference in refractive error between the two eyes. 'hypermetropia' (≥3.5 D), 'myopia' (≥-4.0 D), 'astigmatism' (≥1.5 D). 'structural abnormalities' of the eye will not be excluded, but will be considered to have vision loss if visual acuity is 20/40 or worse.	Device: Pediatric Vision Scanner eye scan Subject is scanned with a 2.5 second pediatric vision scanner device test.
Borderline (no long-term harm to patient if referral is delayed, however the patient does have conditions that might benefit from monitoring): Equal visual acuity and no structural abnormality with any of the following: Amblyogenic factor, intermittent strabismus, structural abnormalities, refractive error, reduced stereopsis.	Device: Pediatric Vision Scanner eye scan Subject is scanned with a 2.5 second pediatric vision scanner device test.

Arm

Intervention/Treatment

Normal Controls

Structurally normal eye with equal visual acuity and normal stereopsis.

Device: Pediatric Vision Scanner eye scan

Subject is scanned with a 2.5 second pediatric vision scanner device test.

Referral required

Diagnosed with amblyopia or constant strabismus, categorized based on the GSE. Amblyopia: VA <20/40 and 2 logMAR lines difference in normal eye Mild amblyopia (>20/40) Moderate amblyopia (20/40 and <20/100) Severe amblyopia (≥20/100 or worse) Bilateral amblyopia: >4 years age VA<20/40 OU including high hyperopia or high astigmatism. Strabismus: Constant: >2 PD at near and or distance. Intermittent: strabismus that could be controlled intermittently either through fusional mechanisms or a compensatory head position. Amblyogenic factor categorization: 'Anisometropia'- (1.5 Diopters (D) or more difference in refractive error between the two eyes. 'hypermetropia' (≥3.5 D), 'myopia' (≥-4.0 D), 'astigmatism' (≥1.5 D). 'structural abnormalities' of the eye will not be excluded, but will be considered to have vision loss if visual acuity is 20/40 or worse.

Device: Pediatric Vision Scanner eye scan

Subject is scanned with a 2.5 second pediatric vision scanner device test.

Borderline

(no long-term harm to patient if referral is delayed, however the patient does have conditions that might benefit from monitoring): Equal visual acuity and no structural abnormality with any of the following: Amblyogenic factor, intermittent strabismus, structural abnormalities, refractive error, reduced stereopsis.

Device: Pediatric Vision Scanner eye scan

Subject is scanned with a 2.5 second pediatric vision scanner device test.

Outcome Measures

Primary Outcome Measures

Binocularity score [Day 1]

Secondary Outcome Measures

Presence of amblyopia risk factors [Day 1]

Eligibility Criteria

Criteria

Ages Eligible for Study:

6 Months to 6 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Children aged 6 months to 6 years
Signed Informed consent by parent or guardian
Meet all inclusion criteria.

Exclusion Criteria:

Children with a history of developmental delay or cognitive deficit
Children unable to complete the GSE (including visual acuity testing)

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Doheny Eye Institute	Los Angeles	California	United States	90033

Sponsors and Collaborators

Rebiscan, Inc.
University of Southern California

Investigators

Principal Investigator: Rohit Varma, MD, PhD, University of Southern California

Study Documents (Full-Text)

None provided.

More Information

Publications

Loudon SE, Rook CA, Nassif DS, Piskun NV, Hunter DG. Rapid, high-accuracy detection of strabismus and amblyopia using the pediatric vision scanner. Invest Ophthalmol Vis Sci. 2011 Jul 7;52(8):5043-8. doi: 10.1167/iovs.11-7503.

Responsible Party:

Rebiscan, Inc.

ClinicalTrials.gov Identifier:

NCT01706991

Other Study ID Numbers:

rebiscan-003

First Posted:

Oct 15, 2012

Last Update Posted:

Oct 15, 2012

Last Verified:

Oct 1, 2012

Additional relevant MeSH terms:

Amblyopia

Strabismus

Study Results

No Results Posted as of Oct 15, 2012